Floatz logo

Idarubicin

Acute Promyelocytic Leukemia

Technische Universität DresdenSmall moleculePhase 4 / ApprovedDormant
A
81/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
95/ 100

Competitive context

20 Active assets in the Acute Promyelocytic Leukemia cohort.

Asset / SponsorPhaseRating
CYTARABINE
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 4A
Tretinoin
The Affiliated People's Hospital of Ningbo University
Phase 4A
Arsenic Trioxide
Quetzal Therapeutics
Phase 4BBB
Mitoxantrone
Technische Universität Dresden
Phase 4BBB
METHOTREXATE
Technische Universität Dresden
Phase 3BBB

View all 50 →

Same molecule, other indications

Idarubicin is also rated in:

acute myeloid leukemia with 11q23 abnormalitiesDormant
BBB
Indicative ·
76 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →
acute myeloid leukemia, del(5q31-q32)Dormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →